Gary Mather

Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450

David A. Erickson, Gary Mather, W. Trager et al. · Drug Metabolism and Disposition · 1999 · 276 citations

Medicine, Pharmacokinetics, Pharmacology +17

Discovery of <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration

Nilantha Sirisoma, Azra Pervin, Hong Zhang et al. · Journal of Medicinal Chemistry · 2009 · 123 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Safety, Tolerability, Pharmacokinetics, and Aβ Levels After Short-term Administration of R-flurbiprofen in Healthy Elderly Individuals

Douglas Galasko, N. R. Graff-Radford, Susanne May et al. · Alzheimer Disease & Associated Disorders · 2007 · 120 citations

Medicine, Pharmacokinetics, Pharmacology +15

In Vitro Evaluation of Potential Drug Interactions With Levetiracetam, A New Antiepileptic Agent

Jean-Marie Nicolas, Philippe Collart, Brigitte Gerin et al. · Drug Metabolism and Disposition · 1999 · 108 citations

Medicine, Pharmacokinetics, Pharmacology +17

Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants*

Agnès Tran, Elisabeth Rey, Gérard Pons et al. · Clinical Pharmacology & Therapeutics · 1997 · 106 citations

Medicine, Pharmacokinetics, Pharmacology +17